Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narman Puvanachandra

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Ophthalmology (Auckland, N.Z.)|March 18, 2026
Correlation Between SUN Scale Grades and AS-OCT Cell Counts in Pediatric Uveitis: A Retrospective Central 7-Frame AnalysisAli S Ibrahim, Trevor Tam, Sean Zhou, et al.
American Journal of Medical Genetics. Part A|February 24, 2007
Vitreous phenotype: a key diagnostic sign in Stickler syndrome types 1 and 2 complicated by double heterozygosityAlan Ang, Tsiang Ung, Narman Puvanachandra, et al.
Lancet (London, England)|January 25, 2025
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trialNisha R Acharya, Athimalaipet V Ramanan, Alison B Coyne, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Ophthalmology (Auckland, N.Z.)|March 18, 2026
Correlation Between SUN Scale Grades and AS-OCT Cell Counts in Pediatric Uveitis: A Retrospective Central 7-Frame AnalysisAli S Ibrahim, Trevor Tam, Sean Zhou, et al.
American Journal of Medical Genetics. Part A|February 24, 2007
Vitreous phenotype: a key diagnostic sign in Stickler syndrome types 1 and 2 complicated by double heterozygosityAlan Ang, Tsiang Ung, Narman Puvanachandra, et al.
Lancet (London, England)|January 25, 2025
Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trialNisha R Acharya, Athimalaipet V Ramanan, Alison B Coyne, et al.
Pageof 2